PPAT and chronic kidney disease: Current data have shown that PRAT size potentiates the lesions produced by other renal metabolic factors, such as abnormal insulin serum levels and increased glucose resistance or high triglycerides and uric acid levels, all these features being observed in patients with chronic kidney disease [10,46].